UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 23, 2004
ENDOCARE, INC.
Delaware
(State or other jurisdiction of incorporation)
| 0-27212 | 33-0618093 | |
| (Commission File Number) | (IRS Employer Identification No.) |
201 Technology Drive, Irvine, California 92618
(Address of principal executive offices, including zip code)
(949) 450-5400
(Registrant’s telephone number, including area code)
| ITEM 5. OTHER EVENTS | ||||||||
| ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT 99.1 | ||||||||
ITEM 5. OTHER EVENTS
On July 23, 2004, Endocare, Inc. (the “Company”) issued a press release (the “Press Release”) announcing the receipt of “Wells Notices” from the Securities and Exchange Commission by two former members and one current member of the Company’s Board of Directors, all of whom are former members of the Company’s Audit Committee. A copy of the Press Release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
| (c) | Exhibits. |
| 99.1 | Press Release, dated July 23, 2004. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
| ENDOCARE, INC. |
||||
| By: | /s/ William J. Nydam | |||
| Date: July 26, 2004 | William J. Nydam | |||
| President & Chief Operating Officer | ||||
2